COMPANY PROFILE

Hinge Bio

Explore full profile

Biotechnology company leveraging a next-generation platform for the development of a new class of flexible

Redwood City, United StatesFounded 2015Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Revenue $10–50M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Hinge Bio

Hinge Bio operates in the biopharmaceutical industry, focusing on developing advanced therapeutic molecules with enhanced binding capabilities to disease targets. The company serves clients in the healthcare sector, particularly those involved in oncology and immuno-oncology. Hinge Bio's unique technology enables cooperative binding to disease targets, significantly improving the activity and specificity of their therapeutic molecules compared to conventional approaches. This results in new functionalities that offer superior safety and efficacy. The business model revolves around the research and development of these advanced therapeutics, progressing from preclinical to clinical stages, and eventually bringing these products to market. Revenue is generated through the development and commercialization of these therapies, as well as potential partnerships and licensing agreements with larger pharmaceutical companies.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Redwood City, United States
Employees: 20
Open positions: None listed
Dealroom signal: 77.2/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Jan 2025	$30M	$120M	InVivium Capital · Point72 · Ridgeback Capital · Lightswitch Capital	↗
GRANTOther financing	May 2018	$220K	—	US National Science Foundation	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Hinge Bio website traffic

Latest recorded traffic for Hinge Bio is 1.6K monthly website visits, up 77.8% over the last three months. Hinge Bio's team grew 11.1% over the past year.

Latest monthly visits1.6K 3-month web change+77.8% 1-year team growth+11.1%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NONovaceptNovacept design, develop, manufacture & market innovative therapeutic devices to improve quality of women healthcare cost-effective manner	Palo Alto, United States	Acquired	—	$30M	$325M
NENerviveFor-profit c-corp that is developing the vitalflow, an emergency treatment for stroke and traumatic brain injury	Akron, United States	Operational
VAVaporeA proprietary germ-free water vapor technology for the therapeutic treatment of a variety of medical conditions	Alameda, United States	Operational
RSReach SurgicalCompany focused on providing surgical instruments and medical equipments, integrating r&d, production, and sales	United States	Operational
ASActa Vascular SystemsActa Vascular Systems specializes in the development and distribution of innovative interventional neuroradiology (INR) devices	San Jose, United States	Acquired
RLReShape LifesciencesDeveloper of minimally invasive medical devices to treat obesity and metabolic diseases	San Clemente, United States	Acquired
RSRa Medical SystemsMedical device company that commercializes laser therapies for a number of dermatology and vascular diseases	Carlsbad, United States	Operational
ZMZSX MedicalPre-clinical stage medical device company	Philadelphia, United States	Operational